CURV
Torrid Holdings Inc.
CURV offers stronger valuation, but that advantage does not outweigh its weaker overall profile.
TSLA
Tesla, Inc.
TSLA has a slight edge over CURV overall, supported by stronger fundamentals and lower modeled downside.
CURV Fundamentals
| Metric | Status |
|---|---|
| Under pressure | |
| Under pressure | |
| Under pressure | |
| Weak |
CURV's revenue, profitability, cash flow and balance sheet are all currently under pressure.
TSLA Fundamentals
| Metric | Status |
|---|---|
| Healthy | |
| Stable | |
| Under pressure | |
| Strong |
TSLA's revenue and balance sheet are currently healthy, and its profitability is stable, but its cash flow is under pressure.
CURV PE Valuation
CURV has no meaningful PE right now: it lost money over the past year. If it returns to profit as analysts expect, today's price would be 40x next year's earnings.
TSLA PE Valuation
| Level | PE | Price | Vs current |
|---|---|---|---|
| Cheap | 60x | $54.70 | -86% |
| Fair | 174x | $158 | -60% |
| Forward | 196x | $397 | — |
| Expensive | 415x | $378 | -4.9% |
| Current | 437x | $397 | — |
Historical ranges are pointers, not guarantees.
TSLA's PE is in its expensive range at 437x. If earnings grow as analysts expect, today's price would be 196x next year's earnings, in its fair range.
CURV Forward outlook
| Metric | Outlook |
|---|---|
| -- | |
| Returning to profit | |
| Stable | |
| Strongly improving | |
| Limited | |
| Low |
Analysts expect CURV to return to profit, with revenue holding steady. However, they disagree widely on these estimates.
TSLA Forward outlook
| Metric | Outlook |
|---|---|
| Strongly improving | |
| Growth | |
| Growth | |
| Stable | |
| Limited | |
| Low |
Analysts expect earnings and revenue growth for TSLA, with profitability holding steady. However, they disagree widely on these estimates.
CURV Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $0.06 | — |
| Q3 2026 | -$0.10 | -433% |
| Q2 2026 | -$0.13 | -244% |
| Q1 2026 | -$0.07 | -147% |
| Q4 2025 | -$0.02 | -113% |
| Q3 2025 | $0.03 | -79% |
| Q2 2025 | $0.09 | -25% |
| Q1 2025 | $0.15 | +36% |
| Q4 2024 | $0.16 | +60% |
CURV has swung to a loss: it lost $0.10 per share over the past year, after a profit the year before.
TSLA Earnings Per Share
| Quarter | TTM EPS | YoY |
|---|---|---|
| Forward | $2.03 | +123% |
| Q3 2026 | $0.91 | -39% |
| Q2 2026 | $1.08 | -38% |
| Q1 2026 | $1.09 | -40% |
| Q4 2025 | $1.08 | -47% |
| Q3 2025 | $1.50 | -59% |
| Q2 2025 | $1.73 | -51% |
| Q1 2025 | $1.82 | -53% |
| Q4 2024 | $2.04 | -53% |
TSLA has the edge over CURV on earnings quality, reporting a profit while its opponent remains loss making.
CURV Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $231.7M | -12% |
| Q2 2026 | $245.8M | -7.6% |
| Q1 2026 | $236.2M | -14% |
| Q4 2025 | $235.2M | -11% |
| Q3 2025 | $262.8M | -7.7% |
| Q2 2025 | $266M | -4.9% |
| Q1 2025 | $275.6M | -6.1% |
| Q4 2024 | $263.8M | -4.2% |
CURV's revenue has slid since its 2022 peak: $232M last quarter, down 12% from the same quarter a year ago.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 6.3% | +2.4 points |
| Q2 2026 | 3.5% | -2.6 points |
| Q1 2026 | -2.1% | -3.4 points |
| Q4 2025 | 0.1% | -2.6 points |
| Q3 2025 | 3.9% | -3.3 points |
| Q2 2025 | 6% | -3.3 points |
| Q1 2025 | 1.3% | -0.1 points |
| Q4 2024 | 2.7% | +0.2 points |
CURV has the edge over TSLA on profitability, with a higher operating margin.
TSLA Quarterly Revenue
| Quarter | Revenue | YoY |
|---|---|---|
| Q3 2026 | $28B | -0.2% |
| Q2 2026 | $28.2B | +26% |
| Q1 2026 | $22.4B | +16% |
| Q4 2025 | $24.9B | -3.1% |
| Q3 2025 | $28.1B | +12% |
| Q2 2025 | $22.5B | -12% |
| Q1 2025 | $19.3B | -9.2% |
| Q4 2024 | $25.7B | +2.1% |
TSLA has the edge over CURV on sales, with more consistent year-over-year improvement.
| Quarter | Margin | YoY |
|---|---|---|
| Q3 2026 | 2.6% | -3.2 points |
| Q2 2026 | 1.4% | -2.7 points |
| Q1 2026 | 4.2% | +2.1 points |
| Q4 2025 | 5.7% | -0.5 points |
| Q3 2025 | 5.8% | -5 points |
| Q2 2025 | 4.1% | -2.2 points |
| Q1 2025 | 2.1% | -3.4 points |
| Q4 2024 | 6.2% | -2 points |
TSLA's operating margin was 2.6% last quarter, down 3.2 points from the same quarter a year ago, near the bottom of its range since 2019.
CURV Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | -$3M | -121% |
| Q2 2026 | $5.7M | +$26.3M |
| Q1 2026 | -$9.3M | -191% |
| Q4 2025 | -$6.6M | -$1.1M |
| Q3 2025 | $14.6M | -61% |
| Q2 2025 | -$20.6M | -200% |
| Q1 2025 | $10.2M | +$12M |
| Q4 2024 | -$5.5M | -$1.9M |
CURV's free cash flow was −$13M over the past year, against −$1M the year before.
TSLA Free Cash Flow
| Quarter | Free cash flow | YoY |
|---|---|---|
| Q3 2026 | $1.5B | -62% |
| Q2 2026 | -$1.1B | -848% |
| Q1 2026 | $1.4B | +117% |
| Q4 2025 | $1.4B | -30% |
| Q3 2025 | $4B | +46% |
| Q2 2025 | $146M | -89% |
| Q1 2025 | $664M | +$3.2B |
| Q4 2024 | $2B | -1.6% |
TSLA has the edge over CURV on cash generation, producing positive trailing cash flow while its opponent burns cash.
CURV Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | +0.7% | +667K shares |
| 1 year | -2.5% | -2.5M shares |
| 3 years | -3.8% | -4M shares |
| 5 years | -8.9% | -9.8M shares |
| Available history | -8.9% | -9.8M shares |
CURV has the edge over TSLA on shareholder dilution, with a more favorable share count trend.
| Quarter | Spent |
|---|---|
| Q3 2026 | — |
| Q2 2026 | $186,000 |
| Q1 2026 | — |
| Q4 2025 | $85,000 |
| Q1 2024 | — |
| Q4 2023 | — |
| Q3 2023 | — |
| Q2 2023 | — |
CURV spent $271,000 buying back its own shares over the past year.
TSLA Total Shares
| Period | Change % | Net change |
|---|---|---|
| Quarterly | 0% | +1M shares |
| 1 year | +0.4% | +15M shares |
| 3 years | +1.4% | +48M shares |
| 5 years | +5.1% | +172M shares |
| Available history | +33% | +886M shares |
TSLA has 3.5B diluted shares, about the same as a year ago.
CURV Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | 5.2x | High |
| Q2 2026 | 5.2x | High |
| Q1 2026 | 4.4x | High |
| Q4 2025 | 3.9x | Elevated |
| Q3 2025 | 3.5x | Elevated |
| Q2 2025 | 3.1x | Elevated |
| Q1 2025 | 2.5x | Moderate |
| Q4 2024 | 2.6x | Moderate |
CURV's net debt is about 5.2 years of its operating earnings (EBITDA), up from 3.5 years a year ago.
TSLA Net Leverage
| Quarter | Net Leverage | Status |
|---|---|---|
| Q3 2026 | -1.1x | Net Cash |
| Q2 2026 | -0.8x | Net Cash |
| Q1 2026 | -0.9x | Net Cash |
| Q4 2025 | -1.1x | Net Cash |
| Q3 2025 | -1.4x | Net Cash |
| Q2 2025 | -1.1x | Net Cash |
| Q1 2025 | -1.1x | Net Cash |
| Q4 2024 | -1.0x | Net Cash |
TSLA has the edge over CURV on leverage, with a lower net debt burden relative to earnings.
CURV Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 51.5 | Neutral |
| Stochastic | 35.0 | Neutral |
CURV's weekly RSI is 51 (neutral) and its Stochastic is 35 (neutral).
TSLA Weekly Momentum
| Metric | Value | Status |
|---|---|---|
| RSI | 54.3 | Neutral |
| Stochastic | 72.6 | Neutral |
TSLA's weekly RSI is 54 (neutral) and its Stochastic is 73 (neutral).
CURV PE vs Consumer Cyclical Sector
| Metric | CURV | Sector median | Relative |
|---|---|---|---|
| PE | N/A | 18x | — |
CURV has no meaningful PE right now: it lost money over the past year.
TSLA PE vs Consumer Cyclical Sector
| Metric | TSLA | Sector median | Relative |
|---|---|---|---|
| PE | 437x | 18x | 2,324% above |
| PE % | 84 | 47 | 37 pts above |
TSLA is trading at 437x earnings, a 2324% premium to the Consumer Cyclical sector's median of 18x.
CURV Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $2.33 | 4.3% below |
| 20 week MA | $2.30 | 3% below |
| 50 week MA | $1.78 | 25% above |
| 100 week MA | $2.88 | 23% below |
| 200 week MA | $3.56 | 37% below |
CURV's trend is mixed: it's above one of its five weekly moving averages, and 37% below its 200-week average.
TSLA Weekly Moving Averages
| Moving average | MA price | Relative |
|---|---|---|
| 8 week MA | $376.0 | 5.7% above |
| 20 week MA | $364.0 | 9.2% above |
| 50 week MA | $393.6 | 1% above |
| 100 week MA | $372.1 | 6.8% above |
| 200 week MA | $296.9 | 34% above |
TSLA has the edge over CURV on trend strength, trading above more of its moving averages.
CURV Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2021 | $26.6 | $10.1 | -62% |
| 2022 | $10.1 | $3.02 | -70% |
| 2023 | $3.02 | $5.77 | +91% |
| 2024 | $5.77 | $5.28 | -8.5% |
| 2025 | $5.28 | $1.04 | -80% |
| 2026 YTD | $1.04 | $2.23 | +114% |
CURV has the edge over TSLA on returns for 2026, with the stronger performance.
TSLA Yearly ROI
| Year | Start price | End price | ROI |
|---|---|---|---|
| 2020 | $28.7 | $220.6 | +669% |
| 2021 | $220.6 | $355.7 | +61% |
| 2022 | $355.7 | $123.2 | -65% |
| 2023 | $123.2 | $248.5 | +102% |
| 2024 | $248.5 | $431.7 | +74% |
| 2025 | $431.7 | $475.2 | +10% |
| 2026 YTD | $475.2 | $397.5 | -16% |
TSLA's yearly returns have swung widely, from +669% in 2020 to −65% in 2022. It's down 16% so far in 2026.